课题基金 / 基金详情

CVD 16000 Malariavax

CVD 16000 Malariavax
CVD 16000 疟疾疫苗
批准号：
6981323
负责人：
Robert R. Edelman
金额：
$1.74万
依托单位：
UNIVERSITY OF MARYLAND BALTIMORE
依托单位国家：
美国
项目类别：
财政年份：
2004
资助国家：
美国
项目状态：
已结题
起止时间：
2004-03-01 至 2005-02-28
来源：
https://reporter.nih.gov/project-details/6981323
关键词：
clinical researchclinical trial phase Idosagedrug adverse effecthuman subjecthuman therapy evaluationmalaria vaccinespatient oriented researchvaccine evaluation

项目成果

Robert R. Edelman的其他基金

相似基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Twofold Reduction in Gadolinium Dose for Brain MRI Exams using a Novel Unbalanced T1 Relaxation-Enhanced Steady-State (uT1RESS) Technique
Twofold Reduction in Gadolinium Dose for Brain MRI Exams using a Novel Unbalanced T1 Relaxation-Enhanced Steady-State (uT1RESS) Technique
Improved Detection of Cerebral Metastases using a using a Novel T1 Relaxation-Enhanced Steady-State (T1RESS) MRI Technique
Improved Detection of Cerebral Metastases using a using a Novel T1 Relaxation-Enhanced Steady-State (T1RESS) MRI Technique
海外基金